Open Access
| Issue |
Med Sci (Paris)
Volume 41, Number 11, Novembre 2025
|
|
|---|---|---|
| Page(s) | 850 - 852 | |
| Section | Nouvelles | |
| DOI | https://doi.org/10.1051/medsci/2025215 | |
| Published online | 12 December 2025 | |
- Siegal FP, Kadowaki N, Shodell M, et al. The nature of the principal type 1 interferon-producing cells in human blood. Science 1999 ; 284 : 1835-7. [Google Scholar]
- Ngo C, Garrec C, Tomasello E, et al. The role of plasmacytoid dendritic cells in immunity during viral infections and beyond. Cell Mol Immunol 2024 ; 21 : 1008-35. [Google Scholar]
- Sisirak V, Faget J, Gobert M, et al. Impaired IFN-α production by plasmacytoid dendritic cells favors regulatory T-cell expansion that may contribute to breast cancer progression. Cancer Res 2012 ; 72 : 5188-97. [Google Scholar]
- Sisirak V, Vey N, Goutagny N, et al. Breast cancer-derived transforming growth factor-β and tumor necrosis factor-a compromise interferon-α production by tumor-associated plasmacytoid dendritic cells. Int J Cancer 2013 ; 133 : 771-8. [Google Scholar]
- Hubert M, Gobbini E, Couillault C, et al. IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer. Sci Immunol 2020 ; 5 : eaav3942. [CrossRef] [PubMed] [Google Scholar]
- Lazear HM, Schoggins JW, Diamond MS. Shared and distinct functions of type I and type III interferons. Immunity 2019 ; 50 : 907-23. [Google Scholar]
- Cao W, Manicassamy S, Tang H, et al. Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway. Nat Immunol 2008 ; 9 : 1157-64. [Google Scholar]
- Sakref C, Saby A, Rodriguez C, et al. Type III interferon primes pDCs for TLR7 activation and antagonizes immune suppression mediated by TGF-β and PGE2. Nat Commun 2025 ; 16 : 3045. [Google Scholar]
- Adams S, Kozhaya L, Martiniuk F, et al. Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancer. Clin Cancer Res 2012 ; 18 : 6748-57. [Google Scholar]
- Borden EC. Interferons a and b in cancer: therapeutic opportunities from new insights. Nat Rev Drug Discov 2019 ; 18 : 219-34. [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.